Search Results - "Parpaleix, A." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

1661MO Genomic somatic copy number alterations drive adaptive tumor immune suppression and primary resistance to anti-PD1 + anti-angiogenics in pleural mesothelioma

1661MO Genomic somatic copy number alterations drive adaptive tumor immune suppression and primary resistance to anti-PD1 + anti-angiogenics in pleural mesothelioma

by Danlos, F-X, Baldini, C., Texier, M., Varga, A., Mouraud, S., Job, B., Letourneur, D., Cassard, L., Bredel, D., Laghouati, S., Adam, J., Droin, N., Parpaleix, A., Chaput-Gras, N., Rabeau, A., Massard, C., Soria, J-C., Zalcman, G., Planchard, D., Marabelle, A.
Published in Annals of oncology (01.09.2022)

Get full text

Journal Article

1742P Phase II study of rucaparib and atezolizumab (ARIANES): Results in patients (pts) with platinum-sensitive metastatic urothelial cancer (mUC) and metastatic castration-resistant prostate cancer (mCRPC)

1742P Phase II study of rucaparib and atezolizumab (ARIANES): Results in patients (pts) with platinum-sensitive metastatic urothelial cancer (mUC) and metastatic castration-resistant prostate cancer (mCRPC)

by Martin Romano, P., Roubaud, G., Lavaud, P., Cabart, M., Pages, A., Vasseur, D., Colomba, E., Cousin, S., Toulmonde, M., Grellety, T., Castel Ajgal, Z., Chabanon, R., Parpaleix, A., Buzzatti, G., Fizazi, K., Gomez-Roca, C.A., Italiano, A., Loriot, Y., Postel-Vinay, S.
Published in Annals of oncology (01.09.2022)

Get full text

Journal Article

1732MO Pembrolizumab and nintedanib for patients with advanced mesothelioma

1732MO Pembrolizumab and nintedanib for patients with advanced mesothelioma

by Danlos, F-X., Baldini, C., Varga, A., Mouraud, S., Job, B., Letourneur, D., Cassard, L., Bredel, D., Laghouati, S., Texier, M., Adam, J., Droin, N., Parpaleix, A., Chaput, N., Rabeau, A., Zalcman, G., Planchard, D., Massard, C., Soria, J-C., Marabelle, A.
Published in Annals of oncology (01.09.2021)

Get full text

Journal Article

984P Phase I dose escalation trial of nintedanib in combination with pembrolizumab in patients with advanced solid tumors (PEMBIB trial)

984P Phase I dose escalation trial of nintedanib in combination with pembrolizumab in patients with advanced solid tumors (PEMBIB trial)

by Baldini, C., Danlos, F-X., Varga, A., Halse, H., Mouraud, S., Cassard, L., Bredel, D., Escriou, G., Parpaleix, A., Rafie, S., Abbassi, A.E., Laghouati, S., Farhane, S., Tselikas, L., Texier, M., Adam, J., Chaput, N., Soria, J-C., Massard, C., Marabelle, A.
Published in Annals of oncology (01.09.2021)

Get full text

Journal Article

A71 ONCOGENES AND ANGIOGENESIS IN LUNG TUMORS: Antioxidant Treatment Can Promote Lung Tumor Formation During Chronic Oxidative Stress

A71 ONCOGENES AND ANGIOGENESIS IN LUNG TUMORS: Antioxidant Treatment Can Promote Lung Tumor Formation During Chronic Oxidative Stress

by Breau, M, Marcos, E, Parpaleix, A, Abid, S, Houssaini, A, Bizard, E, Boyer, L, Tiendrebeogo, A, Van Nhieu, T, Bernard, D, Mechta-Gregoriou, F, Adnot, S
Published in American journal of respiratory and critical care medicine (01.01.2017)

Get full text

Journal Article

D27 I WANNA BE YOUR ... NOVEL MECHANISTIC INSIGHT INTO PULMONARY VASCULAR DISEASE: Role For Macrophage And Smooth-Muscle-Cell Cross-Talk Via Ccr2 And Ccr5 In Progression Of Pulmonary Hypertension

D27 I WANNA BE YOUR ... NOVEL MECHANISTIC INSIGHT INTO PULMONARY VASCULAR DISEASE: Role For Macrophage And Smooth-Muscle-Cell Cross-Talk Via Ccr2 And Ccr5 In Progression Of Pulmonary Hypertension

by Abid, S, Parpaleix, A, Amsellem, V, Houssaini, A, Breau, M, Marcos, E, Sawaki, D, Bizard, E, Delcroix, M, Quarck, R, Adnot, S
Published in American journal of respiratory and critical care medicine (01.01.2017)

Get full text

Journal Article

156TiP Impact of neoadjuvant immunotherapy in early stage breast cancer before standard therapy (BIS-Program)

156TiP Impact of neoadjuvant immunotherapy in early stage breast cancer before standard therapy (BIS-Program)

by Ribeiro, J.T.M.L.M., Rassy, E., Salabert, L., Viansone, A.A., Parpaleix, A., Blanc, A.S., Mahout, I., Laghouati, S., Mouret Reynier, M.A., Petit, T., André, F., Michiels, S., Dalenc, F., Pistilli, B., Arnedos, M.
Published in ESMO open (01.05.2023)

Get full text

Journal Article

D52 MOLECULAR INSIGHT INTO PULMONARY HYPERTENSION: Dual Targeting Of Ccr2 And Ccr5 For Treating Pulmonary Hypertension

D52 MOLECULAR INSIGHT INTO PULMONARY HYPERTENSION: Dual Targeting Of Ccr2 And Ccr5 For Treating Pulmonary Hypertension

by Parpaleix, A, Amsellem, V, Abid, S, Houssaini, A, Breau, M, Marcos, E, Sawaki, D, Bizard, E, Hubeau, C, Evans, S E, Delcroix, M, Quarck, R, Adnot, S
Published in American journal of respiratory and critical care medicine (01.01.2016)

Get full text

Journal Article

C107 IMMUNITY, EXACERBATION AND IMMUNE CELL FUNCTION IN COPD: Inefficiency Of Influenza Vaccination In COPD Patients Is Associated With Defect Of B Cell Differentiation And Decrease Of Ifn[gamma] Cd4+ T Cells Production

C107 IMMUNITY, EXACERBATION AND IMMUNE CELL FUNCTION IN COPD: Inefficiency Of Influenza Vaccination In COPD Patients Is Associated With Defect Of B Cell Differentiation And Decrease Of Ifn[gamma] Cd4+ T Cells Production

by Parpaleix, A, Boyer, L, Wiedemann, A, Lacabaratz, C, Lino, A, Covali-Noroc, A, Chouaid, C, Maitre, B, Levy, Y, Jean-Daniel, L, Adnot, S
Published in American journal of respiratory and critical care medicine (01.01.2016)

Get full text

Journal Article

D108 CELL FATE DECISIONS: SENESCENCE, REPAIR, AND REGENERATION: Activation Of The Mtor Pathway Drives Lung Cell Senescence And Emphysema In Chronic Obstructive Pulmonary Disease (COPD)

D108 CELL FATE DECISIONS: SENESCENCE, REPAIR, AND REGENERATION: Activation Of The Mtor Pathway Drives Lung Cell Senescence And Emphysema In Chronic Obstructive Pulmonary Disease (COPD)

by Houssaini, A, Breau, M, Kebe, K, Abid, S, Marcos, E, Lipskaia, L, Rideau, D, Parpaleix, A, Huang, J, Amsellem, V, Maitre, B, Bizard, E, Vienney, N, Luka, C, Validyre, P, Boczkowski, J, Derumeaux, G, Bernard, D, Meiners, S, Adnot, S
Published in American journal of respiratory and critical care medicine (01.01.2017)

Get full text

Journal Article

B95 NOVEL THERAPEUTIC TARGETS IN PULMONARY HYPERTENSION: INSIGHTS FROM TRANSLATIONAL AND PRECLINICAL STUDIES: Involvement Of Interleukin-1 Receptor (il1r1) And Myeloid Differentiation Primary Response Gene 88 (myd88) Signaling In Hypoxia-Induced Pulmonary Hypertension (ph) In Mice

B95 NOVEL THERAPEUTIC TARGETS IN PULMONARY HYPERTENSION: INSIGHTS FROM TRANSLATIONAL AND PRECLINICAL STUDIES: Involvement Of Interleukin-1 Receptor (il1r1) And Myeloid Differentiation Primary Response Gene 88 (myd88) Signaling In Hypoxia-Induced Pulmonary Hypertension (ph) In Mice

by Parpaleix, A, Houssaini, A, Latiri, M, Abid, S, Wan, F, Amsellem, V, Ryffel, B, Marcos, E, Couillin, I, Adnot, S
Published in American journal of respiratory and critical care medicine (01.01.2014)

Get full text

Journal Article

A66 PH: MOLECULES, CELLS AND ANIMAL MODELS: Susceptibility To Develop Pulmonary Hypertension In Sad Mice: Effects Of No Donors

A66 PH: MOLECULES, CELLS AND ANIMAL MODELS: Susceptibility To Develop Pulmonary Hypertension In Sad Mice: Effects Of No Donors

by Abid, S, Kebe, K, Houssaini, A, Marcos, E, Bizard, E, Breau, M, Parpaleix, A, Wan, F, Tissot, C, Gary-Bobo, G, Maitre, B, Bastia, E, Mekontso-Dessap, A, Adnot, S
Published in American journal of respiratory and critical care medicine (01.01.2016)

Get full text

Journal Article

A66 PH: MOLECULES, CELLS AND ANIMAL MODELS: Osteopontin, A Key Mediator Expressed By Senescent Pulmonary Vascular Cells And Involved In Pulmonary Hypertension

A66 PH: MOLECULES, CELLS AND ANIMAL MODELS: Osteopontin, A Key Mediator Expressed By Senescent Pulmonary Vascular Cells And Involved In Pulmonary Hypertension

by Marcos, E, Saker, M, Lipskaia, L, Abid, S, Parpaleix, A, Houssaini, A, Validire, P, Noureddine, H, Boyer, L, Vienney, N, Lesaux, C, Maitre, B, Delcroix, M, Quarck, R, Adnot, S
Published in American journal of respiratory and critical care medicine (01.01.2016)

Get full text

Journal Article

A70 THE GOOD, THE BAD, AND THE UGLY OF AGING: Jund Protects Mice From Age-Related Lung Alterations Consisting Of Emphysema, Lymphoid Hyperplasia, And Adenocarcinoma

A70 THE GOOD, THE BAD, AND THE UGLY OF AGING: Jund Protects Mice From Age-Related Lung Alterations Consisting Of Emphysema, Lymphoid Hyperplasia, And Adenocarcinoma

by Breau, M, Marcos, E, Van Nhieu, J Tran, Parpaleix, A, Abid, S, Houssaini, A, Bizard, E, Boyer, L, Tiendrebeogo, A J F, Boczkowski, J, Mechta-Grigoriou, F, Adnot, S
Published in American journal of respiratory and critical care medicine (01.01.2016)

Get full text

Journal Article

C28 MESENCHYMAL STEM CELLS, MARROW, AND MORE IN PULMONARY REMODELING: NEW PLAYERS IN THE PARTY: Differential Effects Of Cx3cr1 And Ccr2 Deficiencies In Hypoxic Pulmonary Hypertension

C28 MESENCHYMAL STEM CELLS, MARROW, AND MORE IN PULMONARY REMODELING: NEW PLAYERS IN THE PARTY: Differential Effects Of Cx3cr1 And Ccr2 Deficiencies In Hypoxic Pulmonary Hypertension

by Amsellem, V, Rodero, M, Abid, S, Poupel, L, Gary-Bobo, G, Latiri, M, Parpaleix, A, Dubois-Rande, J-L, Combadiere, C, Adnot, S
Published in American journal of respiratory and critical care medicine (01.01.2014)

Get full text

Journal Article

C21 MECHANISMS THAT LINK AGING WITH LUNG DISEASE: THE CUTTING EDGE: Senescence Of Pulmonary Vascular Cells Is Related To Overactivation Of The Mtor Signaling Pathway In Chronic Obstructive Pulmonary Disease (COPD)

C21 MECHANISMS THAT LINK AGING WITH LUNG DISEASE: THE CUTTING EDGE: Senescence Of Pulmonary Vascular Cells Is Related To Overactivation Of The Mtor Signaling Pathway In Chronic Obstructive Pulmonary Disease (COPD)

by Houssaini, A, Marcos, E, Saker, M, Kebe, K, Wan, F, Rideau, D, Latiri, M, Breau, M, Parpaleix, A, Amsellem, V, Validire, P, Caniard, A, Meiners, S, Derumeaux, G, Adnot, S
Published in American journal of respiratory and critical care medicine (01.01.2014)

Get full text

Journal Article